nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.13	0.265	CbGbCtD
Levobupivacaine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.104	0.212	CbGbCtD
Levobupivacaine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0679	0.139	CbGbCtD
Levobupivacaine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0631	0.129	CbGbCtD
Levobupivacaine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0507	0.104	CbGbCtD
Levobupivacaine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.029	0.0593	CbGbCtD
Levobupivacaine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0266	0.0544	CbGbCtD
Levobupivacaine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0181	0.0371	CbGbCtD
Levobupivacaine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000609	CcSEcCtD
Levobupivacaine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.00031	0.000606	CcSEcCtD
Levobupivacaine—Infection—Cisplatin—peripheral nervous system neoplasm	0.00031	0.000606	CcSEcCtD
Levobupivacaine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000309	0.000605	CcSEcCtD
Levobupivacaine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000308	0.000602	CcSEcCtD
Levobupivacaine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000602	CcSEcCtD
Levobupivacaine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000307	0.0006	CcSEcCtD
Levobupivacaine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000307	0.0006	CcSEcCtD
Levobupivacaine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000306	0.000599	CcSEcCtD
Levobupivacaine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000306	0.000598	CcSEcCtD
Levobupivacaine—Cough—Etoposide—peripheral nervous system neoplasm	0.000305	0.000597	CcSEcCtD
Levobupivacaine—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000597	CcSEcCtD
Levobupivacaine—Headache—Topotecan—peripheral nervous system neoplasm	0.000305	0.000596	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000304	0.000595	CcSEcCtD
Levobupivacaine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000304	0.000595	CcSEcCtD
Levobupivacaine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000303	0.000593	CcSEcCtD
Levobupivacaine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000303	0.000593	CcSEcCtD
Levobupivacaine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000303	0.000592	CcSEcCtD
Levobupivacaine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000302	0.000592	CcSEcCtD
Levobupivacaine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000302	0.000592	CcSEcCtD
Levobupivacaine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000302	0.000591	CcSEcCtD
Levobupivacaine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000301	0.00059	CcSEcCtD
Levobupivacaine—Pain—Vincristine—peripheral nervous system neoplasm	0.000301	0.00059	CcSEcCtD
Levobupivacaine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000301	0.00059	CcSEcCtD
Levobupivacaine—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000589	CcSEcCtD
Levobupivacaine—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000589	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000301	0.000589	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.000585	CcSEcCtD
Levobupivacaine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000297	0.000582	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000296	0.000579	CcSEcCtD
Levobupivacaine—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000293	0.000574	CcSEcCtD
Levobupivacaine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000291	0.00057	CcSEcCtD
Levobupivacaine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000291	0.000569	CcSEcCtD
Levobupivacaine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000291	0.000568	CcSEcCtD
Levobupivacaine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000289	0.000566	CcSEcCtD
Levobupivacaine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000289	0.000566	CcSEcCtD
Levobupivacaine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000289	0.000565	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000288	0.000564	CcSEcCtD
Levobupivacaine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000288	0.000563	CcSEcCtD
Levobupivacaine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000562	CcSEcCtD
Levobupivacaine—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000562	CcSEcCtD
Levobupivacaine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000287	0.000561	CcSEcCtD
Levobupivacaine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000287	0.000561	CcSEcCtD
Levobupivacaine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000561	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000286	0.000559	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000284	0.000556	CcSEcCtD
Levobupivacaine—Infection—Etoposide—peripheral nervous system neoplasm	0.000284	0.000555	CcSEcCtD
Levobupivacaine—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000554	CcSEcCtD
Levobupivacaine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000283	0.000554	CcSEcCtD
Levobupivacaine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000283	0.000554	CcSEcCtD
Levobupivacaine—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000552	CcSEcCtD
Levobupivacaine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000551	CcSEcCtD
Levobupivacaine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00028	0.000548	CcSEcCtD
Levobupivacaine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000279	0.000545	CcSEcCtD
Levobupivacaine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000279	0.000545	CcSEcCtD
Levobupivacaine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000279	0.000545	CcSEcCtD
Levobupivacaine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000278	0.000544	CcSEcCtD
Levobupivacaine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000277	0.000543	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000276	0.00054	CcSEcCtD
Levobupivacaine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000538	CcSEcCtD
Levobupivacaine—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000531	CcSEcCtD
Levobupivacaine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000271	0.00053	CcSEcCtD
Levobupivacaine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00027	0.000528	CcSEcCtD
Levobupivacaine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00027	0.000527	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000269	0.000526	CcSEcCtD
Levobupivacaine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000267	0.000522	CcSEcCtD
Levobupivacaine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000267	0.000521	CcSEcCtD
Levobupivacaine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.00052	CcSEcCtD
Levobupivacaine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.00052	CcSEcCtD
Levobupivacaine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000262	0.000513	CcSEcCtD
Levobupivacaine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000513	CcSEcCtD
Levobupivacaine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000509	CcSEcCtD
Levobupivacaine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00026	0.000508	CcSEcCtD
Levobupivacaine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000259	0.000506	CcSEcCtD
Levobupivacaine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000257	0.000502	CcSEcCtD
Levobupivacaine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000256	0.000502	CcSEcCtD
Levobupivacaine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000255	0.000498	CcSEcCtD
Levobupivacaine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000254	0.000497	CcSEcCtD
Levobupivacaine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000253	0.000495	CcSEcCtD
Levobupivacaine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000491	CcSEcCtD
Levobupivacaine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000491	CcSEcCtD
Levobupivacaine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000491	CcSEcCtD
Levobupivacaine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000251	0.000491	CcSEcCtD
Levobupivacaine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00025	0.00049	CcSEcCtD
Levobupivacaine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000248	0.000486	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000247	0.000482	CcSEcCtD
Levobupivacaine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000246	0.000482	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000481	CcSEcCtD
Levobupivacaine—Pain—Etoposide—peripheral nervous system neoplasm	0.000244	0.000478	CcSEcCtD
Levobupivacaine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000244	0.000478	CcSEcCtD
Levobupivacaine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000477	CcSEcCtD
Levobupivacaine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000242	0.000473	CcSEcCtD
Levobupivacaine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000241	0.000472	CcSEcCtD
Levobupivacaine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000471	CcSEcCtD
Levobupivacaine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000468	CcSEcCtD
Levobupivacaine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000235	0.00046	CcSEcCtD
Levobupivacaine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000234	0.000458	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000234	0.000457	CcSEcCtD
Levobupivacaine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000233	0.000456	CcSEcCtD
Levobupivacaine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000233	0.000455	CcSEcCtD
Levobupivacaine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000454	CcSEcCtD
Levobupivacaine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000454	CcSEcCtD
Levobupivacaine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000454	CcSEcCtD
Levobupivacaine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00023	0.000449	CcSEcCtD
Levobupivacaine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000449	CcSEcCtD
Levobupivacaine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000229	0.000448	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000445	CcSEcCtD
Levobupivacaine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000227	0.000444	CcSEcCtD
Levobupivacaine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000226	0.000442	CcSEcCtD
Levobupivacaine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000226	0.000442	CcSEcCtD
Levobupivacaine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000442	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000439	CcSEcCtD
Levobupivacaine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000224	0.000438	CcSEcCtD
Levobupivacaine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000224	0.000437	CcSEcCtD
Levobupivacaine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000435	CcSEcCtD
Levobupivacaine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000434	CcSEcCtD
Levobupivacaine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000433	CcSEcCtD
Levobupivacaine—Headache—Vincristine—peripheral nervous system neoplasm	0.000221	0.000432	CcSEcCtD
Levobupivacaine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.000425	CcSEcCtD
Levobupivacaine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000213	0.000417	CcSEcCtD
Levobupivacaine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000415	CcSEcCtD
Levobupivacaine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00021	0.000412	CcSEcCtD
Levobupivacaine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000411	CcSEcCtD
Levobupivacaine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000209	0.00041	CcSEcCtD
Levobupivacaine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000409	CcSEcCtD
Levobupivacaine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000409	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000406	CcSEcCtD
Levobupivacaine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000402	CcSEcCtD
Levobupivacaine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000205	0.000401	CcSEcCtD
Levobupivacaine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000395	CcSEcCtD
Levobupivacaine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000202	0.000395	CcSEcCtD
Levobupivacaine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000394	CcSEcCtD
Levobupivacaine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000198	0.000388	CcSEcCtD
Levobupivacaine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000386	CcSEcCtD
Levobupivacaine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000384	CcSEcCtD
Levobupivacaine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000384	CcSEcCtD
Levobupivacaine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000195	0.000382	CcSEcCtD
Levobupivacaine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.00038	CcSEcCtD
Levobupivacaine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000378	CcSEcCtD
Levobupivacaine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000378	CcSEcCtD
Levobupivacaine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000378	CcSEcCtD
Levobupivacaine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000376	CcSEcCtD
Levobupivacaine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000373	CcSEcCtD
Levobupivacaine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000371	CcSEcCtD
Levobupivacaine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000189	0.000369	CcSEcCtD
Levobupivacaine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000369	CcSEcCtD
Levobupivacaine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000366	CcSEcCtD
Levobupivacaine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000364	CcSEcCtD
Levobupivacaine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000185	0.000362	CcSEcCtD
Levobupivacaine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000362	CcSEcCtD
Levobupivacaine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000357	CcSEcCtD
Levobupivacaine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000182	0.000355	CcSEcCtD
Levobupivacaine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000355	CcSEcCtD
Levobupivacaine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000355	CcSEcCtD
Levobupivacaine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000355	CcSEcCtD
Levobupivacaine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000353	CcSEcCtD
Levobupivacaine—Headache—Etoposide—peripheral nervous system neoplasm	0.000179	0.00035	CcSEcCtD
Levobupivacaine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.00035	CcSEcCtD
Levobupivacaine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000348	CcSEcCtD
Levobupivacaine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000345	CcSEcCtD
Levobupivacaine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000344	CcSEcCtD
Levobupivacaine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000343	CcSEcCtD
Levobupivacaine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000341	CcSEcCtD
Levobupivacaine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000339	CcSEcCtD
Levobupivacaine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000337	CcSEcCtD
Levobupivacaine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000335	CcSEcCtD
Levobupivacaine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000335	CcSEcCtD
Levobupivacaine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000332	CcSEcCtD
Levobupivacaine—Nausea—Etoposide—peripheral nervous system neoplasm	0.00017	0.000332	CcSEcCtD
Levobupivacaine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000331	CcSEcCtD
Levobupivacaine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000328	CcSEcCtD
Levobupivacaine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000327	CcSEcCtD
Levobupivacaine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000326	CcSEcCtD
Levobupivacaine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000326	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000324	CcSEcCtD
Levobupivacaine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000318	CcSEcCtD
Levobupivacaine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000316	CcSEcCtD
Levobupivacaine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000314	CcSEcCtD
Levobupivacaine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000313	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000313	CcSEcCtD
Levobupivacaine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000312	CcSEcCtD
Levobupivacaine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000311	CcSEcCtD
Levobupivacaine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.00031	CcSEcCtD
Levobupivacaine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000308	CcSEcCtD
Levobupivacaine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000308	CcSEcCtD
Levobupivacaine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000307	CcSEcCtD
Levobupivacaine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000306	CcSEcCtD
Levobupivacaine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000306	CcSEcCtD
Levobupivacaine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000304	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000303	CcSEcCtD
Levobupivacaine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000302	CcSEcCtD
Levobupivacaine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000301	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.0003	CcSEcCtD
Levobupivacaine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000293	CcSEcCtD
Levobupivacaine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000292	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00029	CcSEcCtD
Levobupivacaine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00029	CcSEcCtD
Levobupivacaine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000288	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000285	CcSEcCtD
Levobupivacaine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000285	CcSEcCtD
Levobupivacaine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000284	CcSEcCtD
Levobupivacaine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000283	CcSEcCtD
Levobupivacaine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000283	CcSEcCtD
Levobupivacaine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000281	CcSEcCtD
Levobupivacaine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000281	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.00028	CcSEcCtD
Levobupivacaine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000279	CcSEcCtD
Levobupivacaine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000278	CcSEcCtD
Levobupivacaine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000276	CcSEcCtD
Levobupivacaine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000272	CcSEcCtD
Levobupivacaine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000271	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000138	0.00027	CcSEcCtD
Levobupivacaine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000268	CcSEcCtD
Levobupivacaine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000268	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000264	CcSEcCtD
Levobupivacaine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000262	CcSEcCtD
Levobupivacaine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.00026	CcSEcCtD
Levobupivacaine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000258	CcSEcCtD
Levobupivacaine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000258	CcSEcCtD
Levobupivacaine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000258	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000256	CcSEcCtD
Levobupivacaine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000255	CcSEcCtD
Levobupivacaine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000252	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.00025	CcSEcCtD
Levobupivacaine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000249	CcSEcCtD
Levobupivacaine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000248	CcSEcCtD
Levobupivacaine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000248	CcSEcCtD
Levobupivacaine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000248	CcSEcCtD
Levobupivacaine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000248	CcSEcCtD
Levobupivacaine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000239	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000237	CcSEcCtD
Levobupivacaine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000231	CcSEcCtD
Levobupivacaine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00023	CcSEcCtD
Levobupivacaine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000229	CcSEcCtD
Levobupivacaine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000229	CcSEcCtD
Levobupivacaine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000225	CcSEcCtD
Levobupivacaine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000222	CcSEcCtD
Levobupivacaine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000214	CcSEcCtD
Levobupivacaine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000213	CcSEcCtD
Levobupivacaine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000208	CcSEcCtD
Levobupivacaine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000207	CcSEcCtD
Levobupivacaine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000205	CcSEcCtD
Levobupivacaine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000199	CcSEcCtD
Levobupivacaine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000198	CcSEcCtD
Levobupivacaine—Headache—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000196	CcSEcCtD
Levobupivacaine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.79e-05	0.000192	CcSEcCtD
Levobupivacaine—Nausea—Epirubicin—peripheral nervous system neoplasm	9.51e-05	0.000186	CcSEcCtD
Levobupivacaine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	9.42e-05	0.000184	CcSEcCtD
Levobupivacaine—Headache—Doxorubicin—peripheral nervous system neoplasm	9.28e-05	0.000181	CcSEcCtD
Levobupivacaine—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.8e-05	0.000172	CcSEcCtD
